These findings enhance understanding of the mechanism of sepsis‐induced skeletal muscle atrophy and provide evidence that the PLK1‐AKT pathway may be a novel therapeutic target to relieve skeletal muscle atrophy induced by sepsis. This evidence concerns the gene AKT1 and muscle atrophy.